Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy Japanese Participants”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05563454
What this trial is testing

Learn How Safe the Study Treatment BAY2395840 is, How it Affects the Body and How it Moves Into, Through, and Out of the Body if Given in Single and in Repetitive Doses to Japanese Healthy Male Participants

Who this might be right for
Diabetic Neuropathic PainHealthy Volunteers
Bayer 24
Early research (Phase 1)Study completedNCT07222254
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 in Healthy Japanese Participants

Who this might be right for
Healthy Participants
AstraZeneca 18
Early research (Phase 1)Study completedNCT05543369
What this trial is testing

Study to Compare the Level of Elafibranor in Blood After Repeat Administration in Japanese and Non-Asian Healthy Participants

Who this might be right for
Healthy Volunteers
Ipsen 48
Early research (Phase 1)Study completedNCT03984838
What this trial is testing

Study to Evaluate Pharmacokinetics, Safety and Tolerability of Dolutegravir and Rilpivirine (JULUCA™) 50 Milligram (mg)/25 mg Tablets in Healthy Subjects of Japanese Descent

Who this might be right for
HIV Infections
ViiV Healthcare 16
Early research (Phase 1)Study completedNCT06674941
What this trial is testing

A Trial to Investigate Teprotumumab (High-concentration Formulation) Subcutaneous Administration in Healthy Adult Non-Japanese and Japanese Participants

Who this might be right for
Healthy Volunteers
Amgen 44
Early research (Phase 1)Looking for participantsNCT07525947
What this trial is testing

A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants

Who this might be right for
Healthy Volunteers (HV)
Jade Biosciences, Inc. 40
Early research (Phase 1)Study completedNCT05148481
What this trial is testing

Evaluate Safety and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants

Who this might be right for
Healthy Volunteer
Biogen 31
Early research (Phase 1)Looking for participantsNCT07612813
What this trial is testing

Evaluate the Safety and Pharmacokinetics of AZD7760 in Healthy Japanese Adults

Who this might be right for
Staphylococcus Aureus Bloodstream Infection
AstraZeneca 18
Early research (Phase 1)Study completedNCT01494714
What this trial is testing

Evaluate Skin Irritation and Photo Irritation of JNJ 10229570-AAA on Intact Skin of Japanese Healthy Male Participants

Who this might be right for
Healthy Volunteers
Janssen Pharmaceutical K.K. 30
Early research (Phase 1)Study completedNCT06722417
What this trial is testing

A Single Dose Study to Assess Adverse Events and How Oral Icalcaprant Moves Through the Body in Healthy Adult Japanese and Han Chinese Participants

Who this might be right for
Healthy Volunteer
AbbVie 16
Early research (Phase 1)Study completedNCT02354599
What this trial is testing

Single-Dose Study of MT203

Who this might be right for
Healthy Volunteers
Takeda 32
Early research (Phase 1)Study completedNCT02180269
What this trial is testing

A Safety, Tolerability and Pharmacokinetics Study of JNJ-54861911 in Healthy Japanese Male Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 24
Early research (Phase 1)Ended earlyNCT02209506
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants

Who this might be right for
SafetyTolerabilityPharmacokinetics+1 more
Takeda 23
Early research (Phase 1)Study completedNCT03133468
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJM347 in Healthy Male Caucasian and Japanese Subjects in the Fasted and Fed State

Who this might be right for
Healthy Participants
EA Pharma Co., Ltd. 200
Post-approval studies (Phase 4)Study completedNCT02530060
What this trial is testing

Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 8
Early research (Phase 1)Study completedNCT02415790
What this trial is testing

Study to Assess the Safety, Tolerability, Pharmacokinetics of E2027 in Healthy Adult and Elderly Subjects, and the Pharmacodynamics in Healthy Adult Subjects

Who this might be right for
Healthy Participants
Eisai Inc. 112
Early research (Phase 1)Study completedNCT03536325
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of Guselkumab Following a Single Intravenous Administration in Healthy Japanese Participants

Who this might be right for
Healthy
Janssen Pharmaceutical K.K. 24
Early research (Phase 1)Study completedNCT06327880
What this trial is testing

Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin

Who this might be right for
Healthy
Pfizer 6
Early research (Phase 1)Study completedNCT05813717
What this trial is testing

Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 25
Early research (Phase 1)Study completedNCT03564379
What this trial is testing

A Single and Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of JNJ-42165279 in Healthy Japanese Male Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 12
Next Page